CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MEPHOS focuses on developing a new treatment strategy for osteoarthritis using polymeric microplates that release therapeutic agents over time. This innovative approach aims to provide both mechanical support and long-term pain relief, potentially improving the quality of life for millions affected by this degenerative…
Osteoarthritis (OA) is a chronic disease involving the degeneration of articular cartilage and subchondral bone.
It represents the single most common cause of disability in older adults.
Being aging, obesity, trauma and gender risk factors for OA, its societal burden is rapidly rising.
Across EU, over 40 million people are affected by OA.
Current treatment options aim at modulating the symptoms rather than curing this chronic disease.
Consequently, joint replacement continues to be ultimately th…
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Pamplona
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Portugal, Braga
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Israel, Jerusalem
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United States, Stanford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
